Associated Papers
High depth targeted next-generation sequencing in vascular malformations.
Pakhathirathien P et al.
Human Molecular Genetics, 2025
Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations.
Del Carpio LP et al.
European Journal of Cancer (oxford, England : 1990), 2025
A comprehensive benchmark for multiple highly efficient base editors with broad targeting scope.
Wang X et al.
Biorxiv : the Preprint Server for Biology, 2025
39763781 (PubMed )
Supplement: media-3.xlsx › ABE_screen_library
GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular Tumors.
Jansen P et al.
Frontiers in Genetics, 2021
GNAQ Mutations in Diffuse and Solitary Choroidal Hemangiomas.
Francis JH et al.
Ophthalmology, 2019
Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis.
Emelyanova M et al.
Oncotarget, 2017
28881731 (PubMed )
Supplement: oncotarget-08-52304-s002.xlsx › Sheet1
Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
Scholz SL et al.
Investigative Ophthalmology & Visual Science, 2017
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.
Sheng X et al.
European Journal of Cancer (oxford, England : 1990), 2016
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp.
Costa S et al.
The American Journal of Surgical Pathology, 2016
Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi.
Hawkes JE et al.
Frontiers in Oncology, 2013
Select a paper to view details